Sellas disclosed that it had 196.6 million shares of common stock outstanding as of June 2, 2026, according to an SEC filing.
Sellas believes GPS-treated AML patients could live longer than those receiving standard treatment, with a projected survival ...
Stocktwits on MSN
SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout
CNBC's Jim Cramer called Sellas Life Sciences "a great spec" and gave the biotech stock "two thumbs up" during Mad Money's Lightning Round. ・Investor focus remains on Sellas' Phase 3 Regal trial ...
Stocktwits on MSN
SLS stock tanks hard: Retail traders blame warrant holders, 'flippers' cashing out before AML catalyst
Retail investors said heavy warrant activity may have injected another $20 million-$30 million into Sellas’ cash position, while helping clear the stock’s warrant overhang. ・Some traders also blamed ...
SLS Las Vegas Grand Opening coverage from the Las Vegas Sun, Nevada's locally owned and independent news source.
SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer ...
NASA's Space Launch System (SLS) rocket for the Artemis 2 mission stands at 322 feet tall. The SLS is NASA's most powerful rocket, generating 8.8 million pounds of thrust. While massive, the SLS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results